PCA Skin Intensive Pigment Eraser

Manufacturer
PCA Skin
Effective date
2019-06-20
Label type
HUMAN OTC DRUG LABEL
Version
4
Source
legacy-cache
Hydrated at
2026-08-02 00:20:29

Label at a glance#

ProductPCA Skin Intensive Pigment Eraser
Active ingredientPYRITHIONE ZINC
Label structure7 sections

Dosage and administration

Adults:  Apply a small amount as a thin layer on the affected area twice daily or use as directed by a physician. If no imporvement is seen after 3 months of treatment, use of this product should be discontinued. Lightening effect of this product may not be noticeable when used on very dark skin. Sun exposure should be limited by using a sunscreen agent or protective clothing when using or after using this product...

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

Active Ingredient

Pyrithione Zinc 2%

OTC - PURPOSE SECTION

Purpose: Skin Lightener

Indications

INDICATIONS & USAGE SECTION

For gradual fading of discolorations of th eskin such as freckels, age and liver spots, pigment in the skin that may occur from pregnancy of the use of oral contraceptives.

Warnings

WARNINGS SECTION

For External use only.

When using this product

OTC - WHEN USING SECTION

  • Avoid contact with the eyes.
  • Some users of this product may experience a mild skin irritation.
  • Do not use on children under 12 years of age unless directed by a physician
Stop use and consult a physician

OTC - STOP USE SECTION

If skin irritation becomes severe.

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

Adults:  Apply a small amount as a thin layer on the affected area twice daily or use as directed by a physician.

  • If no imporvement is seen after 3 months of treatment, use of this product should be discontinued.
  • Lightening effect of this product may not be noticeable when used on very dark skin.
  • Sun exposure should be limited by using a sunscreen agent or protective clothing when using or after using this product in order to prevent darkening from recurring.

Other Ingredients

INACTIVE INGREDIENT SECTION

Water, PEG-12 Glyceryl Dimyristate, Isododecane, Niacinamide, 1,2 Propanediol, Glycerin, Caprylic/Capric Triglyceride, Tapioca Starch, Polymethylsilsesquioxane, PEG-8, Dimethicone, Panthenol, Cetearyl Alcohol, Glyceryl Stearate, PEG-100 Stearate, Polysilicone-11, Sodium Phytate,
Coco-Caprylate/Caprate, Ammonium Acryloyldimethyltaurate/VP Copolymer,  Hexyl Resorcinol, PEG-23 Glyceryl Distearate, Phenoxyethanol,
Retinol, Tocopheryl Acetate, Polysorbate 20, Sodium Polyacrylate, Butylene Glycol, Bisabolol, Palmeria Palmata Extract, Caprylyl Glycol, Mentha Piperita (Peppermint) Extract, Ceramide NP, Xanthan Gum, Chlorphenesin, Ethylhexyl Stearate, Hydrolyzed Ceratonia Siliqua Seed Extract,
Avena Sativa (Oat) Kernel Extract, Trideceth-6, Decyl Glucoside, Propyl Gallate, Pentylene Glycol, Citrus Grandis (Grapefruit) Peel Oil
Citric Acid

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Pigment EraserPigment Eraser

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 2 · 44 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
68726-33568726-335-01, 68726-335-02

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 2 · 43 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
dfbe77bc-3b8f-4ce7-b984-03a48e971c902c232f5c-e08b-40b6-926e-79f053278bc62020-05-07WarningsExact identifier
spl set id: 2c232f5c-e08b-40b6-926e-79f053278bc6

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.